Autoapproved post by listing owner

At: 9/16/2024 | Categories: Category #1

Comments

First Expert, 10/18/2024

Promoter

Test comment from a promoter

Alexander Novikov , Space Test., 11/4/2024

Admin Promoter Chief Executive Officer

test

Alexander Novikov , Space Test., 4/14/2025

Admin Chief Executive Officer

test

Investors

Company Owners

Get To Know Us

Resources

Browse Offerings

Raise Capital

Our Team

FAQs

Morsels of Knowledge

News & Press

About Reg CF

Refer a company, earn $5k

Glossary

Disclosure

© 2024 BioTech Social Inc. (“BSI”). This site is provided by BSI, which is the parent company of BioTech Social Crowdfunding Platform, LLC, “The BioTech Funding Portal” (collectively, “BioTech Social”). The BioTech Funding Portal is a funding portal member of the Financial Industry Regulatory Authority (FINRA) registered with the US Securities and Exchange Commission (SEC).

The BioTech Funding Portal offers investments under Regulation Crowdfunding (Title III) to anyone 18 years or older. According to 17 C.F.R. § 227.303(c), a funding portal must "... provide on its platform communication channels by which persons can communicate with one another and with representatives of the issuer about offerings made available on the intermediary's platform..."

The BioTech Funding Portal does not provide investment advice, recommendations or suitability determinations. Past performance is not a guarantee of future results. Further, we do not provide tax, accounting, legal or regulatory advice. Investors must make their own investment decisions and should conduct their own due diligence prior to investing.

Investment offerings are speculative, illiquid, and involve a high degree of risk, including the risk of loss of your entire investment. Past performance of any security, company or project does not guarantee future results.

By using our website, you are subject to our Terms of Use, our Privacy Policy, and you agree to this Electronic Consent. Please read these carefully before using the website.

Hide Disclosure